Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News electroCore, Inc. ECOR

Healthcare Medical Devices
electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company. It provides non-invasive vagus nerve stimulation (nVNS) technology platform. The Company’s product categories include Handheld, personal use medical devices for the management and treatment of certain medical conditions such as primary headache, and Handheld, personal use consumer products utilizing nVNS... see more

Recent & Breaking News (NDAQ:ECOR)

electroCore's Truvaga(TM) Plus Wins Woman's World Magazine 50 over 50 Award

GlobeNewswire 2 days ago

electroCore Donates gammaCore Sapphire for Real World Evaluation of nVNS in Trauma Among Israelis

GlobeNewswire 3 days ago

electroCore to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 21

GlobeNewswire 8 days ago

electroCore Announces Third Quarter 2024 Financial Results

GlobeNewswire 9 days ago

ElectroCore's Truvaga(TM) Plus Wins Men's Health Magazine Tech Award

GlobeNewswire 10 days ago

electroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire November 8, 2024

electroCore to Announce Third Quarter September 30, 2024 Financial Results on Wednesday, November 13, 2024

GlobeNewswire October 23, 2024

electroCore to Participate at LD Micro Main Event VXII

Newsfile October 14, 2024

electroCore to Participate in Upcoming Investor Conferences

GlobeNewswire September 26, 2024

electroCore Engages FNK IR to Execute Expanded Investor Relations Program

GlobeNewswire September 24, 2024

Study Suggests Non-invasive Vagus Nerve Stimulation (nVNS) is effective in accelerating United States Air Force Pilot Training

GlobeNewswire September 10, 2024

electroCore to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

GlobeNewswire September 4, 2024

Ecora Resources PLC Announces Half year results

Accesswire September 4, 2024

electroCore to Participate in Upcoming Investor Conferences

GlobeNewswire August 8, 2024

electroCore Announces Second Quarter 2024 Financial Results

GlobeNewswire August 7, 2024

electroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire August 2, 2024

Non-invasive Vagus Nerve Stimulation (nVNS) is effective at accelerating foreign language learning

GlobeNewswire August 1, 2024

electroCore to Announce Second Quarter June 30, 2024 Financial Results on Wednesday, August 7, 2024

GlobeNewswire July 31, 2024

electroCore Announces the Commercial Launch of TAC-STIM(TM)

GlobeNewswire June 25, 2024

electroCore to Join Russell Microcap® Index

GlobeNewswire June 11, 2024